In part 1 of this interview, Estelle Everett, MD, explores the impact of provider bias and clinic barriers on access to diabetes technology. She shares how improving access to tools like continuous glucose...
In part 1 of this interview, Estelle Everett, MD, explores the impact of provider bias and clinic barriers on access to diabetes technology. She shares how improving access to tools like continuous glucose...
In part 1 of this interview, Estelle Everett, MD, explores the impact of provider bias and clinic barriers on access to diabetes technology. She shares how improving access to tools like continuous glucose...
Consolidation therapy with intermediate- to high-dose cytarabine is crucial in the prevention of acute myeloid leukemia relapse. In this Q&A, Kendall Diebold, DNP, FNP-C, answers questions...
Consolidation therapy with intermediate- to high-dose cytarabine is crucial in the prevention of acute myeloid leukemia relapse. In this Q&A, Kendall Diebold, DNP, FNP-C, answers questions...
Although most of the literature on home insulin pump use currently focuses on adults with type 1 diabetes, Sarah Lawson, MD, and her team recently developed a study that looks at the pediatric population....
Although most of the literature on home insulin pump use currently focuses on adults with type 1 diabetes, Sarah Lawson, MD, and her team recently developed a study that looks at the pediatric population....
Although most of the literature on home insulin pump use currently focuses on adults with type 1 diabetes, Sarah Lawson, MD, and her team recently developed a study that looks at the pediatric population....
Although most of the literature on home insulin pump use currently focuses on adults with type 1 diabetes, Sarah Lawson, MD, and her team recently developed a study that looks at the pediatric population....
Although most of the literature on home insulin pump use currently focuses on adults with type 1 diabetes, Sarah Lawson, MD, and her team recently developed a study that looks at the pediatric population....
